Cancer
Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
Published in Gene Therapy Weekly, September 25th, 2008
The net proceeds of the private placement will be used to advance the Company's clinical development programs, including lead product JX-594, which is currently being evaluated in a randomized Phase II clinical trial for liver cancer. This is one of three clinical trials currently under way, which...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2008-09-25)
More Articles from Gene Therapy Weekly
- Bladder Cancer
Reports from University of Florida, Medical Department advance knowledge in bladder cancer - Cancer Gene Therapy
Data on cancer gene therapy published by S.K. Pavelic and colleagues - Cancer Gene Therapy
Findings from University of Texas in cancer gene therapy reported - Cancer Gene Therapy
Research in the area of cancer gene therapy reported from National University - Colitis
Reports from Vanderbilt University, Medical Department describe recent advances in colitis - Cystic Fibrosis
Study data from University of Bari update understanding of cystic fibrosis - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
